Customer success story

Acrux

We conduct a range of transactions involving intellectual property from around the world.

Acrux logo
Industry:
Healthcare
Field:
Corporate
Advisor:
Credit Suisse
The platform strengthens the relationships we have with our potential overseas buyers of our clinical data.

"We conduct a range of transactions involving intellectual property from around the world. Geography is always a challenge because potential buyers of our IP are usually overseas.

We share highly confidential, market sensitive clinical results which cannot be allowed to be altered or falsified in any way – so security is our number one priority. ansarada offers the highest level of security controls to ensure compliance.

With Ansarada we upload confidential documents and give interested parties access to them anywhere in the world, via a web browser.

The platform strengthens the relationships we have with our potential overseas buyers of our clinical data by giving them the freedom to do everything from their desk, in their own time, without having to travel.

I have gotten incredibly positive feedback from possible buyers on ansarada, who have commented that it was very easy to use, quick and accessible.”

Director, Acrux

An agreement for up to $US335 million plus royalties with Eli Lilly (NYSE: LLY) as the worldwide exclusive licensing partner for Axiron™, indicated for the treatment of testosterone deficiency (hypogonadism) in men.

Ansarada Pathways - the fastest and easiest way to any outcome

Get confidence from proven workflows, processes and best practices

  • Clear and comprehensive checklists of all the information you’ll need
  • Easily adapted, templated and can be reused to suit the needs of any sized company or transaction
  • Pathways are based on global best practice and benchmarked against 30,000+ previous deals

Get in touch

to find out how Ansarada will safeguard your reputation and add more value to your clients.
Contact us